search icon

    Market Snapshot

    blog search icon

    ME Stock Price History and Quote Analysis: Insights for Investors

    23andMe Holding Co.



    -0.09 (-3.95%)

    At Close: 4:00 PM


    -0.03 (-1.32%)

    Pre Market: 6:31 AM

    ME Stock Price Graph

    • 1D
    • 5D
    • 1M
    • 3M
    • 6M
    • 1Y
    • YTD
    • All

    ME Stock Price Today

    23andMe Holding Co. (ME) stock declined over -3.95% intraday to trade at $2.19 a share on NASDAQ. The stock opened with a loss of -0.88% at $2.26 and touched an intraday high of $2.29, falling -3.95% against the last close of $2.28. The 23andMe Holding Co. in stock market went to a low of $2.17 during the session.

    ME Stock Snapshot


    Prev. Close

    1.02 Billion

    Market Cap


    Day Low



    453.41 Million

    Number of Shares


    Day High


    P/E ratio


    EPS (TTM)


    Cash Flow per Share


    Free Float in %


    Book Value



    Contact Details

    349 Oyster Point Boulevard
    South San Francisco, CA 94080
    United States


    Contact #:650 938 6300

    Company Information



    Sales or Revenue$307.67 Million

    5Y Sales Change-

    Fiscal Year EndsMar. 2022

    SectorHealth Care

    IndustryHealth Care Services

    About Company

    23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.

    Frequently Asked Questions


    What is the current 23andMe Holding Co. (ME) stock price?

    23andMe Holding Co. (NASDAQ: ME) stock price is $2.19 in the last trading session. During the trading session, ME stock reached the peak price of $2.29 while $2.17 was the lowest point it dropped to. The percentage change in ME stock occurred in the recent session was -3.95% while the dollar amount for the price change in ME stock was -$0.09.


    ME's industry and sector of operation?

    The NASDAQ listed ME is part of Health Care Services industry that operates in the broader Health Care sector. 23andMe Holding Co. operates as a consumer genetics testing company.


    Who are the executives of ME?

    Ms. Anne Wojcicki
    Co-Founder, Chief Executive Officer, Pres & Director
    Dr. Wade Walke
    Vice President of Investor Relations
    Mr. Mike Polcari
    Vice President & Chief Architect
    Ms. Savita Pillai
    Vice President of People


    How ME did perform over past 52-week?

    ME's closing price is 0.08% higher than its 52-week low of $2.02 where as its distance from 52-week high of $6.31 is -0.65%.


    How many employees does ME have?

    Number of ME employees currently stands at 728. ME operates from 349 Oyster Point Boulevard, South San Francisco, CA 94080, United States.


    Link for ME official website?

    Official Website of ME is:


    How do I contact ME?

    ME could be contacted at phone #650 938 6300 and can also be accessed through its website. ME operates from 349 Oyster Point Boulevard, South San Francisco, CA 94080, United States.


    How many shares of ME are traded daily?

    ME stock volume for the day was 1,581,653 shares. The average number of ME shares traded daily for last 3 months was 2.31 Million.


    What is the market cap of ME currently?

    The market value of ME currently stands at $1.02 Billion with its latest stock price at $2.19 and 453.41 Million of its shares outstanding.